Objective To investigate the effectiveness of conservative interventions for pain, function and range of motion in adults with shoulder impingement.
Design Systematic review and meta-analysis of randomised trials.
Data sources Medline, CENTRAL, CINAHL, Embase and PEDro were searched from inception to January 2017.
Study selection criteria Randomised controlled trials including participants with shoulder impingement and evaluating at least one conservative intervention against sham or other treatments.
Results For pain, exercise was superior to non-exercise control interventions (standardised mean difference (SMD) −0.94, 95% CI −1.69 to −0.19). Specific exercises were superior to generic exercises (SMD −0.65, 95% CI −0.99 to −0.32). Corticosteroid injections were superior to no treatment (SMD −0.65, 95% CI −1.04 to −0.26), and ultrasound guided injections were superior to non-guided injections (SMD −0.51, 95% CI −0.89 to −0.13). Nonsteroidal anti-inflammatory drugs (NSAIDS) had a small to moderate SMD of −0.29 (95% CI −0.53 to −0.05) compared with placebo. Manual therapy was superior to placebo (SMD −0.35, 95% CI −0.69 to −0.01). When combined with exercise, manual therapy was superior to exercise alone, but only at the shortest follow-up (SMD −0.32, 95% CI −0.62 to −0.01). Laser was superior to sham laser (SMD −0.88, 95% CI −1.48 to −0.27). Extracorporeal shockwave therapy (ECSWT) was superior to sham (−0.39, 95% CI −0.78 to –0.01) and tape was superior to sham (−0.64, 95% CI −1.16 to −0.12), with small to moderate SMDs.
Conclusion Although there was only very low quality evidence, exercise should be considered for patients with shoulder impingement symptoms and tape, ECSWT, laser or manual therapy might be added. NSAIDS and corticosteroids are superior to placebo, but it is unclear how these treatments compare to exercise.
- Shoulder Impingement
- Systematic Review
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Statistics from Altmetric.com
Shoulder complaints are the third common musculoskeletal presentation after back and neck disorders in primary care, and shoulder disorders account for 10% of referrals to physiotherapy in the Netherlands.1 The incidence of shoulder complaints is 29.3 per 1000 person-years2 and the 1-year prevalence, 21%;3 with the highest incidence and prevalence in women and persons aged 45–64 years. Among people with shoulder pain, shoulder impingement syndrome (SIS) has the highest prevalence and accounts for 36% of shoulder disorders.4
SIS is a generic term for injury of structures in the subacromial space, such as rotator cuff tendinosis, partial thickness tears of the rotator cuff and bursitis.5 The aetiology of rotator cuff injury and its relationship to subacromial impingement, the encroachment of the involved structures, are still a matter of debate.6
The common consequences of SIS are pain and disability, loss of quality of life and sleep disturbances.7 An ongoing impingement process with serious rotator cuff damage can lead to complete joint destruction and end in a replacement of the glenohumeral joint.8 Tears in the rotator cuff tendons are common in symptomatic shoulders, whereas up to 16.9% of asymptomatic shoulders also demonstrate tears in the rotator cuff.9 The prevalence increases with age.10
The main treatment goals for patients with SIS are to reduce the common impairments related to pain, and to improve upper extremity function.
Systematic reviews and meta-analysis5 11–39 have investigated treatment effects in patients with shoulder impingement. However, missing are (1) a comprehensive overview of all relevant interventions, (2) outcomes from all levels of disability, that is, impairments and activity limitations or participation restrictions40 and (3) an outcome selection based on an a priori stated hierarchy.
The aim of this systematic review and meta-analysis of randomised trials was to provide a comprehensive overview of the effectiveness of all relevant non-surgical interventions for adults with shoulder impingements and outcomes on impairment (pain and active range of motion (AROM)), activity limitation or participation restriction (shoulder function questionnaires) based on an a priori stated hierarchy.
We followed the recommendations of the PRISMA statement for the conduct and reporting of this review.41
Information sources and search strategy
To answer the question about the relative effects of conservative interventions for shoulder impingement, the Cochrane Database of Systematic Reviews, Cochrane Controlled Clinical Trials Register (CENTRAL), Embase, Medline, CINAHL, and PEDro were searched (search strategy in online supplementary appendix 1) for randomised controlled trials, published as full text in peer-reviewed journals from inception to January 2017. Only Chinese and Farsi language articles were excluded. Relevant reviews and selected articles were also screened for potentially relevant studies (see flow chart in online supplementary appendix 1). Trials that enrolled patients with shoulder impingement diagnosed with a minimal set of diagnostic criteria (one criteria fulfilled of the box ‘Complaints of shoulder pain’ in table 1, or diagnosed by MRI or ultrasound) and any kind of conservative interventions were eligible for inclusions.
Trials were included if surgery was compared with conservative interventions but not if only different types of surgery or postoperative interventions were compared. Trials that included patients with calcifying tendinitis, frozen shoulders, treatments after surgery and secondary impingement were excluded.
The protocol of this review was presented to an expert committee but not published or registered. Some amendments were made to the protocol after inclusion of the studies but prior to data analysis. This refers, for example, to the amendment of the hierarchy of outcome measures, (ie, which outcome measure should be selected if several measures were used for one outcome) or the refraining from performing a network meta-analysis because of clinical heterogeneity.
Study selection criteria and selection process
Each title and abstract was independently screened by pairs of researchers (RS, CK, SE, RH), based on established criteria. Full texts were independently screened by two authors (RS, RH). Disagreement was resolved by consensus, and a third author (MS) was consulted if consensus could not be reached.
Data extraction process
The lead author extracted data of the characteristics of the individual trials and all outcomes for all time points into spreadsheets. A second author (RH) checked the data for accuracy. The primary outcomes considered in this systematic review were pain and shoulder function. The secondary outcome was range of motion. Outcomes were extracted from the longest available follow-up (for main analysis) and the first time point available after the end of the intervention period (for sensitivity analysis). For all outcomes, we defined, a priori, a hierarchy of outcome measures based on the literature and theoretical considerations, and extracted data accordingly (table 2). When a study reported multiple scales for a given outcome, the highest on the hierarchy of pain and shoulder function related scale was chosen (table 2). If reported, change score from baseline to the follow-up were extracted, or else postintervention scores were used.42
Risk of bias
The Cochrane Collaboration’s tool was used to assess the risk of bias in each included article.43 Each article was graded (unclear, low or high risk of bias) based on sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, other possible bias, intention-to-treat analysis, selective reporting and baseline characteristics. The risk of bias assessment was completed by one author (RS) and checked by a second author (MS). Disagreements were resolved by discussion, and a third author (RH) was consulted if consensus could not be reached.
Quality of evidence
The Grades of Recommendation Assessment, Development, and Evaluation44 tool was used to assess the overall quality of evidence. For every comparison, evidence started out to be strong. We decreased the level of evidence by 1 for each of the following factors: risk of bias, inconsistency of results, indirectness, imprecision and other biases, such as reporting bias.
This process of analysis was completed by using a combination of GRADE systematic and traffic alert action, that is, how confident we are that it is effective or useless for each intervention and for all outcomes (table 3; adapted from reference 45).45
Data management and synthesis
Individual study effect sizes were expressed as standardised mean differences (SMDs), calculated as the difference in means between the two groups, divided by the pooled SD of the measurement. For pain and shoulder function, the sign of the extracted scores was changed according to the idea that higher scores meant worse outcome. Hence, a negative effect size indicated a beneficial effect for the experimental group. AROM scores were intuitively handled differently with higher scores indicating a better outcome. A positive effect size indicated a beneficial effect for the experimental group. If data were missing, we tried to contact the corresponding author. If mean or SDs were not reported, we used different methods to estimate those values (eg, extracting these data from figures, using median and IQR, p values or CIs).43
Each intervention was compared against different control groups such as other treatments, usual care or sham treatments. In this review, we used the term active intervention or active control for all treatments that were not placebo, sham or ‘doing nothing’. The term passive control was used for all sham or placebo interventions.43
We decided to use a random effects model a priori. Weighting factors were calculated using the DerSimonean and Laird method.46 Presence of heterogeneity was tested using a χ2 test (Q value) and its corresponding degrees of freedom and p value. The extent of heterogeneity was analysed using Higgins’ I2 value (expressed as %). We used a funnel plot to assess publication bias in those comparisons with at least 10 trials.47
To test the robustness of the overall weighted effect sizes, a sensitivity analysis was conducted by extracting results for the first time point available after the end of the intervention period. For example, if a study reported results at several follow-up time points (eg, immediately after the intervention period and at 3 months and 6 months), the 6-month data were used for the primary analysis (called longest follow-up) and the data from immediately after the intervention period were used for the sensitivity analysis (called shortest follow-up). Meta-analyses were performed in RevMan V.5.3.48 In addition, for each risk of bias item, we calculated the differences in the effect sizes between studies with low risk of bias in this item and the studies with unclear or high risk of bias in this item. To test the influence of each risk of bias item on the effect size, we calculated the differences, and corresponding 95% CIs, between low risk and high risk of bias effect sizes. This was repeated for all risk of bias items.
Study selection and characteristics
The electronic database search yielded 9351 studies, from which we screened 324 articles in full text screening (figure 1). Ultimately, we included 200 articles for analysis—177 in the quantitative synthesis (meta-analysis) and 23 in the qualitative synthesis (appendix 2). Ten trials had small samples sizes (n<20),49–54 whereas most of the studies had sample sizes ranging from 20 to 232 participants. Most studies included participants who were between 18 years and 65 years of age, while the duration of symptoms varied widely across the trials. Injection tests were used in 22 trials, 26 trials used unilateral shoulder problem as inclusion criteria. Two trials included only women or only men.55 56 In 50 trials there was a greater proportion of female participants than male participants. Insufficient data were reported in 23 studies; we were able to obtain two additional data files.
Risk of bias and quality of evidence
In 90% (n=159) of trials the random sequence generation was adequate. Adequate allocation concealment was observed as low risk of bias in 30% (n=54), unclear in 61% (n=108) and high risk of bias in 9% (n=15) of the included trials. Outcome assessors were blinded in 64% (n=114), while incomplete outcome data in 54% (n=96), and intention-to-treat analysis were reported in 50% (n=89) of trials (see online supplementary appendix 5).
For all comparisons and outcomes, the quality of evidence was graded as very low.
It was appropriate to assess a funnel plot in one comparison (corticosteroids vs active controls) with 20 trials. The funnel plot had slight asymmetry, indicating a possible risk of publication bias. All other comparisons had less than 10 trials, so funnel plots were not examined.
Across all comparisons, trials with an unclear or high risk of bias on allocation concealment had a significantly greater effect than trials with correct allocation concealment for pain, indicating a small bias (SMD of 0.28 (95% CI 0.05 to 0.51)). For function, AROM, and other risk of bias items in our sensitivity analyses, such as blinded outcome assessor for observer-based outcomes and intention-to-treat, there was no significant difference between trials with high risk and low risk of bias.
Meta-analysis: outcome pain
Hundred and one comparisons from 184 trials with 10 529 patients were included in this meta-analysis. Table 4 summarises the significant results from comparisons including at least 100 patients. Online supplementary appendix 3a shows all summary effect sizes, the Higgins’ I2 measure of heterogeneity (in %) and the level of evidence from the GRADE rating approach. Online supplementary appendix 4a shows all forest plots for the 101 comparisons. The strongest, but still very low quality, evidence for the reduction in pain was found for the following treatments:
Corticosteroids were superior to control (6 studies, n=372, SMD −0.65, 95% CI −1.04 to −0.26)
Corticosteroids were superior to active controls (physical therapy modalities), but only at the shortest follow-up (20 studies, n=1394, SMD −0.25, 95% CI −0.46 to −0.05)
Ultrasound guided corticosteroid injections were superior to blind injections (5 studies, n=298, SMD −0.51, 95% CI −0.89 to −0.13).
Nonsteroidal anti-inflammatory drugs (NSAIDs) had a small advantage over placebo (1 study; n=306, SMD −0.29, 95% CI −0.53 to −0.05)
Local anaesthetics were inferior to corticosteroids, but only at the shortest follow-up (4 studies, n=207, SMD 0.45, 95% 0.17 to 0.73).
Exercise was superior to doing nothing (5 studies, n=189, SMD −0.94, 95% CI −1.69 to −0.19)
Specific exercise was superior to non-specific exercise (2 studies, n=145, SMD −0.65, 95% CI −0.99 to −0.32)
Exercise was less effective than surgery if analysed with a dichotomised outcome (2 studies, n=105, risk difference 31%, 95% CI 13% to 49%).
Manual therapy was superior to placebo (4 studies, n=137, SMD −0.35, 95% CI −0.69 to −0.01)
Manual therapy plus exercise was superior to exercise alone, but only at the shortest follow-up (9 studies, n=363, SMD −0.32, 95% CI −0.62 to −0.01)
There were immediate effects after one session of manual therapy compared with sham (3 studies, n=134, SMD −0.62, 95% CI −0.97 to −0.28).
Ultrasound, laser, extracorporeal shockwave therapy (ECSWT), tape or nerve block
Long duration ultrasound was superior to short duration ultrasound (1 study, n=100, SMD −1.32, 95% CI −1.76 to −0.89)
Laser was superior to sham laser (3 studies, n=128, SMD −0.88, 95% CI −1.48 to −0.27)
Laser plus exercise was superior to sham laser plus exercise (6 studies, n=313, SMD −0.65, 95% CI −0.99 to −0.31)
ECSWT was superior to sham-ECSWT (3 studies, n=117, SMD of −0.39, 95% CI −0.78 to −0.01)
Tape superior to sham tape (5 studies, n=272, SMD −0.64, 95% CI −1.16 to −0.12)
Nerve block was superior to control (3 studies, n=129, SMD −0.91, 95% CI −1.27 to −0.54).
All other conservative interventions (hyaluronate, ultrasound, pulsed electromagnetic field, transcutaneous electrical nerve stimulation (TENS), myofascial trigger point therapy, acupuncture, diacutaneous fibrolysis, microwave and interferential light therapy) showed either non-significant results or significant results but with a very low number of patients (n<100).
Meta-analysis: outcome function
Ninenty-seven comparisons from 173 trials with 10 621 patients were included in this meta-analysis. Table 4 summarises the significant results from comparisons including at least 100 patients. Online supplementary appendix 3b shows all summary effect sizes, the Higgins’ I2 measure of heterogeneity (in %) and the level of evidence from the GRADE rating tool. Online supplementary appendix 4b shows all forest plots for all 97 comparisons.
The strongest, but still very low quality, evidence for the improvement in shoulder function was found for the following treatments:
Corticosteroids were superior to control (5 studies, n=362, SMD −0.56, 95% CI −1.06 to −0.05)
Ultrasound guided corticosteroid injections were superior to blind injections, but only for the shortest follow-up (4 studies, n=298, SMD −0.43, 95% CI −0.71 to −0.15).
Exercise was superior to doing nothing (4 studies, n=202, SMD −0.57, 95% CI −0.85 to −0.29)
Specific exercise was superior to non-specific exercise (2 studies, n=145, SMD −0.68, 95% CI −1.26 to −0.10).
Manual therapy plus exercise was superior to sham ultrasound and placebo gel (1 study, n=120, SMD −0.42, 95% CI −0.78 to –0.06)
Manual therapy plus exercise was superior to exercise alone, but only in the shortest follow-up (7 studies, n=301, SMD −0.41, 95% CI −0.71 to −0.11).
Long duration ultrasound was superior to short duration ultrasound (one study, n=100, SMD −0.42, 95% CI −0.82 to −0.02).
Tape was superior to sham tape, but only in the shortest follow-up (3 studies, n=161, SMD −0.52, 95% CI −1.00 to −0.04).
All other conservative interventions (hyaluronate, laser, ECSWT, ultrasound, pulsed electromagnetic field, TENS, myofascial trigger point therapy, acupuncture, diacutaneous fibrolysis, microwave, interferential light therapy and nerve block) showed either non-significant results or significant results but with a very low number of patients (n<100).
Meta-analysis: outcome AROM
Sixty-nine comparisons from 113 trials with 6093 patients were included in this meta-analysis. Table 4 summarises the significant results from comparisons including at least 100 patients. Online supplementary appendix 3a shows all summary effect sizes, the Higgins’ I2 measure of heterogeneity (in %) and the level of evidence from the GRADE rating tool. Online supplementary appendix 4c shows all forest plots for all 69 comparisons.
The strongest, but still very low quality, evidence for the improvement in active shoulder range of motion was found for the following treatments:
NSAIDS were superior to control (one study, n=306, SMD 2.62, 95% CI 2.25 to 3.00 for celecoxib and SMD 3.10, 95% CI 2.69 to 3.50 for naproxen).
Exercise vs physical therapy modalities such as ultrasound, TENS, electrotherapy (four studies, n=152, SMD 1.00, 95% CI 0.25 to 1.76).
All other conservative interventions (manual therapy, hyaluronate, laser, ECSWT, ultrasound, pulsed electromagnetic field, TENS, myofascial trigger point therapy, acupuncture, diacutaneous fibrolysis, microwave, interferential light therapy and nerve block) showed either non-significant results or significant results but with a very low number of patients (n<100).
Numbers are effect sizes presented as SMDs with corresponding 95% CIs. Here, we only report effect sizes if they were statistically significant and if at least 100 patients were in the comparison. If both longest and shortest follow-up were statistically significant, we only present the longest follow-up. All summary effect sizes are reported in online supplementary appendix 4a (pain and function) and online supplementary appendix 3b (AROM). All complete forest plots are reported in online supplementary appendices 4a, 4b and 4c.
This systematic review and meta-analysis includes 200 trials comparing strategies to treat shoulder impingement. There was very low quality evidence that for pain and function (1) corticosteroid injections were superior to doing nothing, and ultrasound guided corticosteroid injection was superior to blind injection; (2) exercise was superior to doing nothing, and specific exercise was superior to non-specific exercise. For pain, (3) manual therapy was superior to doing nothing or sham, manual therapy plus exercise was superior to exercise alone (but only at the shorter follow-ups) and manual therapy had immediate effects; and (4) laser was superior to sham. Finally, (5) for AROM exercise was superior to non-exercise physical therapy modalities. The quality of evidence was very low for all comparisons because of high risk of bias, lack of precision, lack of consistency and clinical heterogeneity.
Strength and limitations of this review
There have been previously published reviews on SIS,12 13 16 18 57 but only one review57 included all conservative interventions for SIS, and reported the outcomes pain, shoulder function and AROM. Therefore, our meta-analysis provides a comprehensive overview. Another strength of this study is its systematic approach. We followed a stringent protocol and rigorously controlled every step of the process by two or more researchers. We are confident to have included most of the trials reporting on SIS. We used current recommendation to judge the risk of bias of the studies and we used the GRADE approach for the rating of the quality of evidence.58 It could have been expected that the large number of studies and participants would allow to provide strong evidence for or against the different interventions. However, the methodological quality, the large clinical and statistical heterogeneity, and the low number of participants for most of the comparisons reduced the level of evidence to very low quality evidence. We have only low confidence in the overall effect size of our different meta-analyses. The underlying true population effect sizes might be substantially different from our estimated effect sizes. Nevertheless, some of the observed effects are large and therefore, despite the very low quality of evidence, we are confident that there is still a likely beneficial effect of the interventions.
The included trials had some specific limitations: There was a broad clinical diversity (such as duration of symptoms, diagnostic criteria used, sex ratio), and varying length of follow-up periods. Most of the included trials had a high risk of bias. It is suggested to either restrict the meta-analysis to studies with low risk of bias or to present the results of low risk of bias studies separately from those with high risk of bias. Because only few studies could be classified as low risk of bias, such an approach might have introduced selection bias in our systematic review.59 Therefore, we decided to include all studies and to perform a sensitivity analysis to evaluate the influence of the high risk of bias studies.
There is a lack of uniformity in the concept of SIS. Braman et al60 argued to abandon the diagnosis impingement syndrome and to investigate more homogenous groups of patients. Two reviews on diagnostic tests proposed to use a battery of tests to confirm SIS.21 61 For example, to confirm SIS, three out of five tests need to be positive and SIS can be ruled out if less than three out of five tests are positive.62 Furthermore, the use of multiple tests could help to build a more homogenous group. The use of modern diagnostic technics, so far not routinely used in randomised trials, will enhance the inclusion process and support homogenous grouping.60 In our review only 61 trials out of 200 confirmed the diagnosis of shoulder impingement and related stage I–III with ultrasound or MRI. Because of insufficient reporting of patients’ characteristics regarding classification of impingement (ie, stage I–III) we were not able to perform separate analysis for the different stages. This would be an important analysis, as each stage needs different intervention targets. The interventions might have varying effects in the different stages.
Including trials with varying length of follow-up periods resulted in additional heterogeneity. Follow-up periods in future trials need to be longer to learn more about the course of SIS.63 In our meta-analysis 137 studies assessed patients within 2 weeks after end of treatment, 54 studies at 6 weeks, 52 studies at the end of 3 months, 24 studies up to 6 months, whereas only 21 studies had a follow-up longer than 6 months, and in 3 studies the length of follow-up was unclear.51 64 65
Not all interventions were compared against validated sham interventions or placebo. Non-valid sham interventions might disclose blinding of the participants and hence lead to a falsely increased (biassed) effect size in some of the comparisons against sham interventions. For example, there exist validated sham procedures for manual therapy.66
We found a higher proportion of women in the included trials, which is in line with survey data on 2144 Japanese patients having SIS, of whom 60% were women and 40% were men.67 Hence, with regard to gender mix, our results are generalisable.
Unfortunately, we had to exclude several trials (n=23) for the quantitative analysis because of missing data. However, it is unlikely that those missing results would have changed our reported evidence on effect.
Comparisons with other studies
There exist several other reviews, although previous reviews have focused on fewer interventions.14–16 19 28 57 The most important difference between our systematic review, and previously published reviews is that we have a more stringent assessment of the risk of bias and quality of included trials. This is important because the strength of recommendations (eg, in future guidelines) will be based on the quality of the evidence. Furthermore, we performed a meta-analysis and decided to evaluate heterogeneity with I2 statistics, although we refrained from doing a network meta-analysis because of the high clinical heterogeneity.
For exercise, our results are in line with the other reviews, with the exception that we concluded that there is only very low quality evidence where other studies reported moderate14 or even high or strong evidence.15 38 Two reviews evaluated scapula-focused treatments, reporting moderate evidence,36 and significant but clinically not relevant effects;68 whereas we did not separately analyse the scapula-focused treatments.
Two previous reviews18 57 concluded that exercise (stretching and strengthening of the rotator cuff and scapular muscles) was as effective as surgery. This contrasts with our interpretation that there is insufficient evidence to state whether exercise is as good as surgery. We classified studies comparing exercise to surgery as being at very high risk of bias. Therefore, our differing interpretation may be first due to our more severe rating of the risk of bias (eg, we classified Haahr et al69 70 and Ketola et al71 72 as high risk of bias studies, whereas Saltychev18 classified them as low risk of bias. One argument for a high risk of bias rating was the fact that in the study by Haahr et al69 70 6 out of 43 patients in the exercise group were operated, 5 of them because of unsatisfactory improvements with exercise, and in the study by Ketola et al71 72 14 patients from 70 allocated to the exercise group underwent surgery). Second, we also analysed a dichotomised pain outcome, which showed very low quality evidence for an advantage of surgery. However, we cannot exclude that a subset of patients may benefit from surgery.
Acupuncture has been recommended as a first choice to be added to exercises for the treatment of early stage shoulder impingement,13 whereas we did not find enough evidence to make a statement in favour or against acupuncture. Our results for corticosteroid injections were in line with other reviews,22 24 although we classified the evidence as a lower level of evidence (very low quality compared with moderate to strong in).15 Our review supports previous findings14 regarding low quality evidence for manual therapy. We found positive results for laser, although previous reviews are conflicting about whether laser is16 or is not13 57 effective. This might be because previous reviews have included fewer studies,13 and have not performed a meta-analysis and probably based their statements of evidence on non-significance of the individual trials.57 Our results for ultrasound therapy, hyaluronate, tape, pulsed electromagnetic field therapy, ECSWT, microwave and platelet-rich plasma support previous reviews.11 13
Implication for research
Larger trials that employ rigorous methodology to reduce the risk of bias studies and follow patients for longer than 6 months should be performed. Future trials must include homogenous populations, regarding clinical presentation, diagnostic criteria and duration of symptoms.60 Also, health economic evaluations alongside such trials are needed to assess the cost-effectiveness and cost utility of different interventions. In studies comparing surgery with conservative interventions a clinical decision rule should be evaluated,73 to distinguish patients who will only benefit from surgery from those who will recover with conservative treatments. Further research is also needed to evaluate exercise modalities and strategies to increase exercise adherence.
Implication for practice
Although our review only provides very low quality evidence, we suggest that exercise may be considered as the core conservative treatment for shoulder impingement. Furthermore, manual therapy, laser and tape might provide additional benefit. Surgery may be a valid alternative after unsuccessful conservative treatments, and for patients with clearly distinguished clinical signs. Most shoulder surgeons in the UK use a minimum period of 12 weeks of conservative treatments and at least two subacromial steroid injections.74
Exercise, especially shoulder-specific exercises, should be prescribed for all patients with shoulder impingement. The addition of manual therapy, tape, ECSWT and laser might add a small benefit. For other non-exercise physical therapy modalities, we cannot provide enough evidence for or against, therefore they should only be used in addition with exercise. Corticosteroid injections seems to be a valid alternative only when exercise or other modalities are not possible while NSAIDS can be helpful, if necessary, in addition to exercise. Future research should evaluate treatments applied to patients with a more clearly defined diagnosis.
What is already known
There exist several systematic reviews and meta-analyses on the treatment of shoulder impingement.
A comprehensive review including all conservative treatments is missing.
What are the new findings
Exercise therapy was effective in improving pain, function and active range of motion.
Specific exercises were more effective than general shoulder exercises.
NSAIDS, corticosteroid injections (with an advantage for ultrasound guided injections), manual therapy, tape in combination with exercise, extracorporeal shockwave therapy and laser were also effective.
The quality of evidence was very low, therefore clinicians should apply this evidence cautiously when making clinical decisions.
The authors thank Ralph Hertel MD, PhD, and Annika Reintam Blaser MD, PhD, for critically reviewing the manuscript.
Contributors RS, RH, AT, JT conceived the study and wrote the protocol. RS, RH, SE, CK and MS selected studies and extracted data. RS, RH, JT and MS analysed the data. All authors interpreted the data. RS wrote the first draft of the manuscript and all authors contributed to the writing of the final version.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Correction notice This paper has been amended since it was published Online First. Owing to a scripting error, some of the publisher names in the references were replaced with 'BMJ Publishing Group'. This only affected the full text version, not the PDF. We have since corrected these errors and the correct publishers have been inserted into the references.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.